Yilmaz Capan

Yilmaz Capan

Auto-generated profile, based on publicly available information

Yilmaz Capan

Lokman Hekim University

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2017 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
ASAdem Sahin
Adem Sahin
GEGunes Esendagli
Gunes Esendagli
FYFirat Yerlikaya
Firat Yerlikaya
SCSecil Caban-Toktas
Secil Caban-Toktas
DYDigdem Yoyen-Ermis
Digdem Yoyen-Ermis
YCYilmaz Capan
Yilmaz Capan
In this study, it was aimed to investigate characteristics and intracellular delivery of two different-sized PLGA nanoparticles in ouzo region by considering number of nanoparticles. To determine the effect of formulation parameters on average particle size, Dil labeled nanoparticles were prepared using a three-factor, two-level full factorial statistical experimental design. PLGA230 (230.8 ± 4.32 nm) and PLGA160 (157.9 ± 6.16 nm) nanoparticles were obtained by altering polymer amount based on experimental design results and characterized. Same number of PLGA230 and PLGA160 nanoparticles per cell were applied onto HEK293 cells; then, cytotoxicity, uptake kinetics and mechanism were evaluated by flow cytometry and fluorescent microscopy. Also same weight of PLGA230 and PLGA160 nanoparticles were applied and cellular uptake of these nanoparticles was evaluated. It was found that PLGA230 nanoparticles had higher encapsulation efficiency and slower dye release compared to PLGA160 nanoparticles. When they were applied at same counts per cell, PLGA230 nanoparticles displayed faster and higher intracellular dye transfer than PLGA160 nanoparticles. On the other hand, PLGA160 appeared to be a more effective vehicle than PLGA230 when applied at the same weight concentration. It was also shown that for both nanoparticles, HEK293 cells employed macropinocytic, caveolae- and clathrin-mediated endocytic pathways.

1 October 2013 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
FYFirat Yerlikaya
Firat Yerlikaya
AOAysegul Ozgen
Aysegul Ozgen
IVImran Vural
Imran Vural
OGOlgun Guven
Olgun Guven
EKErgun Karaagaoglu
Ergun Karaagaoglu
YCYilmaz Capan
Yilmaz Capan

6 September 2017 in Journal of Microencapsulation
Verified
Journal Article
Closed access
ASAdem Sahin
Adem Sahin
DYDigdem Yoyen-Ermis
Digdem Yoyen-Ermis
SCSecil Caban-Toktas
Secil Caban-Toktas
UHUtku Horzum
Utku Horzum
YAYesim Aktas
Yesim Aktas
YCYilmaz Capan
Yilmaz Capan
The blood–brain barrier (BBB) is the major problem for the treatment of central nervous system diseases. A previous study from our group showed that the brain-targeted chitosan nanoparticles-loaded with large peptide moieties can rapidly cross the barrier and provide neuroprotection. The present study aims to determine the efficacy of the brain-targeted chitosan nanoparticles’ uptake by the human BBB cerebral microvessel endothelial cells (hCMECs) and to investigate the underlying mechanisms for enhanced cellular entry. Fluorescently labelled nanoparticles either conjugated with antibodies recognising human transferrin receptor (anti-TfR mAb) or not were prepared, characterised and their interaction with cerebral endothelial cells was evaluated. The antibody decoration of chitosan nanoparticles significantly increased their entry into hCMEC/D3 cell line. Inhibition of cellular uptake by chlorpromazine indicated that the anti-TfR mAb-conjugated nanoparticles were preferentially cell internalised through receptor-mediated endocytosis pathway. Alternatively, as primarily observed with control chitosan nanoparticles, aggregation of nanoparticles may also have induced macropinocytosis.

1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SCSecil Caban-Toktas
Secil Caban-Toktas
ASAdem Sahin
Adem Sahin
SLSevda Lule
Sevda Lule
GEGunes Esendagli
Gunes Esendagli
IVImran Vural
Imran Vural
YCYilmaz Capan
Yilmaz Capan

1 March 2007 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
JFJabar A. Faraj
Jabar A. Faraj
Dorati RossellaDorati Rossella
Dorati Rossella
ASAurélie Schoubben
Aurélie Schoubben
DWDavid Worthen
David Worthen
FSFrancesca Selmin
Francesca Selmin
PDPatrick P. DeLuca
Patrick P. DeLuca

1 April 2021 in Analytica Chimica Acta
Verified
Journal Article
Closed access
MYMeral Yüce
Meral Yüce
FSFatma Sert
Fatma Sert
MTMilad Torabfam
Milad Torabfam
APAyhan Parlar
Ayhan Parlar
BGBUSRA GUREL
BUSRA GUREL
YÇYılmaz Çapan
Yılmaz Çapan